Jose Ordovas-Montanes

Jose Ordovas-Montanes

Auto-generated profile, based on publicly available information

Jose Ordovas-Montanes

Broad Institute of MIT and Harvard, Cambridge, MA, USA

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2020 in Cell
Verified
Journal Article
Open access
CZCarly G.K. Ziegler
Carly G.K. Ziegler
SASamuel J. Allon
Samuel J. Allon
SNSarah K. Nyquist
Sarah K. Nyquist
IMIan M. Mbano
Ian M. Mbano
VMVincent N. Miao
Vincent N. Miao
KZKun Zhang
Kun Zhang
There is pressing urgency to understand the pathogenesis of the severe acute respiratory syndrome coronavirus clade 2 (SARS-CoV-2), which causes the disease COVID-19. SARS-CoV-2 spike (S) protein binds angiotensin-converting enzyme 2 (ACE2), and in concert with host proteases, principally transmembrane serine protease 2 (TMPRSS2), promotes cellular entry. The cell subsets targeted by SARS-CoV-2 in host tissues and the factors that regulate ACE2 expression remain unknown. Here, we leverage human, non-human primate, and mouse single-cell RNA-sequencing (scRNA-seq) datasets across health and disease to uncover putative targets of SARS-CoV-2 among tissue-resident cell subsets. We identify ACE2 and TMPRSS2 co-expressing cells within lung type II pneumocytes, ileal absorptive enterocytes, and nasal goblet secretory cells. Strikingly, we discovered that ACE2 is a human interferon-stimulated gene (ISG) in vitro using airway epithelial cells and extend our findings to in vivo viral infections. Our data suggest that SARS-CoV-2 could exploit species-specific interferon-driven upregulation of ACE2, a tissue-protective mediator during lung injury, to enhance infection.

1 July 2019 in Cell
Verified
Journal Article
Closed access
CSChristopher S. Smillie
Christopher S. Smillie
MBMoshe Biton
Moshe Biton
JOJose Ordovas-Montanes
Jose Ordovas-Montanes
KSKeri M. Sullivan
Keri M. Sullivan
GBGrace Burgin
Grace Burgin
ARAviv Regev
Aviv Regev

1 November 2018 in Cell
Verified
Journal Article
Closed access
MBMoshe Biton
Moshe Biton
AHAdam L. Haber
Adam L. Haber
NRNoga Rogel
Noga Rogel
GBGrace Burgin
Grace Burgin
SBSemir Beyaz
Semir Beyaz
RXRamnik J. Xavier
Ramnik J. Xavier

22 August 2018 in Nature
Verified
Journal Article
Closed access
PDF file
JOJose Ordovas-Montanes
Jose Ordovas-Montanes
DDDaniel F. Dwyer
Daniel F. Dwyer
SNSarah K. Nyquist
Sarah K. Nyquist
KBKathleen M. Buchheit
Kathleen M. Buchheit
MVMarko Vukovic
Marko Vukovic
ASAlex K. Shalek
Alex K. Shalek

23 April 2014 in Nature
Verified
Journal Article
Open access
PDF file
LRLorena Riol-Blanco
Lorena Riol-Blanco
JOJose Ordovas-Montanes
Jose Ordovas-Montanes
MPMario Perro
Mario Perro
ENElena Naval
Elena Naval
ATAude Thiriot
Aude Thiriot
UAUlrich H. von Andrian
Ulrich H. von Andrian
In mice, it is possible to induce a psoriasis-like condition by applying imiquimod; here, the production of interleukin-23 that is stimulated by such skin inflammation is shown to depend on the interaction of nociceptors expressing the Nav1.8 and TRPV1 channels with skin-resident dendritic cells. Repeated topical application of the antiviral immune modifier imiquimod (IMQ) to murine skin provokes interleukin-23-mediated inflammatory lesions that resemble human psoriasis. Ulrich von Andrian and colleagues show that the production of skin inflammation in this disease model depends on the interaction of a subset of sensory neurons expressing the ion channels TRPV1 and Nav1.8 with skin-resident dendritic cells. Taken together with other recent work, this finding suggests a scenario in which noxious pain fibres integrate environmental signals to modulate local immune responses to a variety of infectious and pro-inflammatory stimuli. The skin has a dual function as a barrier and a sensory interface between the body and the environment. To protect against invading pathogens, the skin harbours specialized immune cells, including dermal dendritic cells (DDCs) and interleukin (IL)-17-producing γδ T (γδT17) cells, the aberrant activation of which by IL-23 can provoke psoriasis-like inflammation1,2,3,4. The skin is also innervated by a meshwork of peripheral nerves consisting of relatively sparse autonomic and abundant sensory fibres. Interactions between the autonomic nervous system and immune cells in lymphoid organs are known to contribute to systemic immunity, but how peripheral nerves regulate cutaneous immune responses remains unclear5,6. We exposed the skin of mice to imiquimod, which induces IL-23-dependent psoriasis-like inflammation7,8. Here we show that a subset of sensory neurons expressing the ion channels TRPV1 and Nav1.8 is essential to drive this inflammatory response. Imaging of intact skin revealed that a large fraction of DDCs, the principal source of IL-23, is in close contact with these nociceptors. Upon selective pharmacological or genetic ablation of nociceptors9,10,11, DDCs failed to produce IL-23 in imiquimod-exposed skin. Consequently, the local production of IL-23-dependent inflammatory cytokines by dermal γδT17 cells and the subsequent recruitment of inflammatory cells to the skin were markedly reduced. Intradermal injection of IL-23 bypassed the requirement for nociceptor communication with DDCs and restored the inflammatory response12. These findings indicate that TRPV1+Nav1.8+ nociceptors, by interacting with DDCs, regulate the IL-23/IL-17 pathway and control cutaneous immune responses.

16 May 2020 in Gastroenterology
Verified
Journal Article
Closed access
VMVanessa Mitsialis
Vanessa Mitsialis
SWSarah Wall
Sarah Wall
PLPeng Liu
Peng Liu
JOJose Ordovas-Montanes
Jose Ordovas-Montanes
TPTamar Parmet
Tamar Parmet
Liza KonnikovaLiza Konnikova
Liza Konnikova